Lacto-N-neotetraose (LNnT), a pivotal oligosaccharide in human milk, plays a significant role in modulating the intestinal microbiota of infants, and exhibits potential applications in antiviral therapy. Corynebacterium glutamicum is widely used in industrial fermentation, but it is incapable of synthesizing LNnT under natural conditions. Previously, we constructed a recombinant C. glutamicum strain CL014 for LNnT production, but the yield was limited. In this study, the key enzyme β-1,4-galactosyltransferase LgtB was engineered to improve LNnT biosynthesis in CL014. Fourteen mutant strains were constructed by replacing the critical residue Arg24 of LgtB to different amino acids and screened for the optimal LNnT production. The highest LNnT production was obtained in the mutant CL014-T. CL014-T could produce 1.40 g/L LNnT in shake flask cultivation, which is a 33.3% increase compared with the control strain CL014. Molecular docking simulations demonstrated that the mutation in CL014-T promotes the formation of additional hydrogen bonds in the flexible loop region, enhancing conformational flexibility and optimizing substrate interactions. Further mechanistic insights obtained through molecular dynamics simulations uncovered that the increased dynamic flexibility in two functional regions and the formation of more core hydrogen bonds collectively contribute to enhanced binding stability and improved product yield in the mutant. After 96 h feed-batch fermentation, CL014-T produced 2.29 g/L LNnT. This work demonstrates that C. glutamicum has the potential to be engineered as an efficient cell factory for human milk oligosaccharide production.
| [1] |
Becker J, Rohles CM, Wittmann C. Metabolically engineered Corynebacterium glutamicum for bio-based production of chemicals, fuels, materials, and healthcare products. Metab Eng, 2018, 50: 122-141
|
| [2] |
Blixt O, van Die I, Norberg T, van den Eijnden DH. High-level expression of the Neisseria meningitidis lgtA gene in Escherichia coli and characterization of the encoded N-acetylglucosaminyltransferase as a useful catalyst in the synthesis of GlcNAc beta 1–>3Gal and GalNAc beta 1–>3Gal linkages. Glycobiology, 1999, 9: 1061-1071
|
| [3] |
Bode L, Jantscher-Krenn E. Structure-function relationships of human milk oligosaccharides. Adv Nutr, 2012, 3: 383s-s391
|
| [4] |
Chen C, Zhang Y, Xue M, Liu X-W, Li Y, Chen X, et al.. Sequential one-pot multienzyme (OPME) synthesis of lacto-N-neotetraose and its sialyl and fucosyl derivatives. Chem Commun, 2015, 51: 7689-92
|
| [5] |
Cleto S, Jensen JV, Wendisch VF, Lu TK. Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth Biol, 2016, 5: 375-385
|
| [6] |
Dong X, Li N, Liu Z, Lv X, Shen Y, Li J, et al.. CRISPRi-Guided multiplexed fine-tuning of metabolic flux for enhanced lacto-n-neotetraose production in Bacillus subtilis. J Agric Food Chem, 2020, 68: 2477-2484
|
| [7] |
Duska-McEwen G, Senft A, Ruetschilling T, Barrett E, Buck R. Human milk oligosaccharides enhance innate immunity to respiratory syncytial virus and influenza in vitro. Food Nut Sci, 2014, 5: 1383-1395
|
| [8] |
Han NS, Kim TJ, Park YC, Kim J, Seo JH. Biotechnological production of human milk oligosaccharides. Biotechnol Adv, 2012, 30: 1268-1278
|
| [9] |
Idänpään-Heikkilä I, Simon PM, Zopf D, Vullo T, Cahill P, Sokol K, et al.. Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia. J Infect Dis, 1997, 176: 704-712
|
| [10] |
Joh NH, Min A, Faham S, Whitelegge JP, Yang D, Woods VL, et al.. Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins. Nature, 2008, 453: 1266-1270
|
| [11] |
Li Z, Zhang D, Tang Y, Zhao G, Liu G, Wang X. Combinatorial metabolic engineering and whole-cell biocatalysis enable high-level lacto-N-neotetraose production in Corynebacterium glutamicum. Syst Microbiol Biomanuf, 2025, 6: 5
|
| [12] |
Liao Y, Lao C, Wu J, Yuan L, Xu Y, Jin W, et al.. High-yield synthesis of lacto-n-neotetraose from glycerol and glucose in engineered Escherichia coli. J Agric Food Chem, 2024, 72: 5325-5338
|
| [13] |
Liu Y-H, Wang L, Huang P, Jiang Z-Q, Yan Q-J, Yang S-Q. Efficient sequential synthesis of lacto-N-triose II and lacto-N-neotetraose by a novel β-N-acetylhexosaminidase from Tyzzerella nexilis. Food Chem, 2020, 332: 127438
|
| [14] |
Liu H, Zeng Q, Zhu C, Zhang S, Chen X, Xu C, et al.. High-throughput screening and directed evolution of β-1,3-n-acetylglucosaminyltransferase for enhanced LNnT production in engineered Saccharomyces cerevisiae. J Agric Food Chem, 2025, 73: 7966-7974
|
| [15] |
Lu N, Wei M, Yang X, Li Y, Sun H, Yan Q, et al.. Growth-coupled production of L-isoleucine in Escherichia coli via metabolic engineering. Metab Eng, 2024, 86: 181-93
|
| [16] |
Malik FK, Guo J-T. Insights into protein–DNA interactions from hydrogen bond energy-based comparative protein–ligand analyses. Proteins, 2022, 90: 1303-14
|
| [17] |
Mark P, Nilsson L. Structure and dynamics of the tip3p, spc, and spc/e water models at 298 K. J Phys Chem A, 2001, 105: 9954-9960
|
| [18] |
Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. Infants fed a lower calorie formula with 2'FL show growth and 2'FL uptake like breast-fediInfants. J Pediatr Gastroenterol Nutr, 2015, 61: 649-658
|
| [19] |
Matsuki T, Yahagi K, Mori H, Matsumoto H, Hara T, Tajima S, et al.. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun, 2016, 7: 11939
|
| [20] |
Moore RE, Xu LL, Townsend SD. Prospecting human milk oligosaccharides as a defense against viral infections. ACS Infect Dis, 2021, 7: 254-263
|
| [21] |
Pérez-Escalante E, Alatorre-Santamaría S, Castañeda-Ovando A, Salazar-Pereda V, Bautista-Ávila M, Cruz-Guerrero AE, et al.. Human milk oligosaccharides as bioactive compounds in infant formula: recent advances and trends in synthetic methods. Crit Rev Food Sci Nutr, 2022, 62: 181-214
|
| [22] |
Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N, et al.. Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. J Pediatr Gastroenterol Nutr, 2017, 64: 624-631
|
| [23] |
Sano C. History of glutamate production. Am J Clin Nutr, 2009, 90: 728s-s732
|
| [24] |
Shah AB, Yoon S, Kim JH, Zhumanova K, Ban YJ, Lee KW, et al.. Effectiveness of cyclohexyl functionality in ugonins from Helminthostachys zeylanica to PTP1B and α-glucosidase inhibitions. Int J Bio Macromol, 2020, 165: 1822-31
|
| [25] |
Sprenger GA, Baumgärtner F, Albermann C. Production of human milk oligosaccharides by enzymatic and whole-cell microbial biotransformations. J Biotechnol, 2017, 258: 79-91
|
| [26] |
Walsh C, Lane JA, van Sinderen D, Hickey RM. Human milk oligosaccharides: shaping the infant gut microbiota and supporting health. J Funct Foods, 2020, 72: 104074
|
| [27] |
Wang T, Li Y, Li J, Zhang D, Cai N, Zhao G, et al.. An update of the suicide plasmid-mediated genome editing system in Corynebacterium glutamicum. Microb Biotechnol, 2019, 12: 907-919
|
| [28] |
Zhang M, Zhang K, Liu T, Wang L, Wu M, Gao S, et al.. High-level production of lacto-n-neotetraose in Escherichia coli by stepwise optimization of the biosynthetic pathway. J Agric Food Chem, 2023, 71: 16212-16220
|
| [29] |
Zhao G, Zhang D, Zhou B, Li Z, Liu G, Li H, et al.. Fine-regulating the carbon flux of L-isoleucine producing Corynebacterium glutamicum WM001 for efficient L-threonine production. ACS Synth Biol, 2024, 13: 3446-3460
|
| [30] |
Zhu L, Li H, Luo T, Deng Z, Li J, Zheng L, et al.. Human milk oligosaccharides: a critical review on structure, preparation, their potential as a food bioactive component, and future perspectives. J Agric Food Chem, 2023, 71: 15908-15925
|
Funding
Basic Research Program of Jiangsu Province(Grant No. BK20233003)
RIGHTS & PERMISSIONS
Jiangnan University
PDF
